CBR3 and breast carcinoma: Secondly, we observed the association of CBR3 (Carbonyl-reductase 3) V244M, a polymorphism that has previously been associated with anthracycline-induced heart failure in childhood cancer patients (9, 16, 17) and in patients with breast cancer (7, 10, 11, 18).